Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 10.10
High: 10.10
Low: 10.10
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

26 Jul 2011 13:01

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are Scancell Holdings plc attached:ii 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the Calculus Capital Limitednotification obligation:iii 4. Full name of shareholder(s) HSBC Global Custody (UK) Limited (if different from 3.):iv 5. Date of the transaction and date on which the threshold is crossed or 26 July 2011reached: v 6. Date on which issuer notified: 26 July 2011 7. Threshold(s) that is/are crossed or 10,11,12,13%reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction Number Number Number Number of voting % of voting rightsif possible of of of shares rights x using Shares Voting the ISIN Rights Direct Direct xi Indirect Direct Indirect CODE xii Ordinary Shares ISIN: 15,277,780 15,277,780 25,277,780 25,277,780 13.02 % GB00B39J5N63 B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting % of voting financial date xiii Conversion Period xiv rights that may be rights instrument acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of Exercise price Expiration Exercise/ Number of voting % of voting financial date xvii Conversion rights instrument rights xix, xx instrument period refers to xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 25,277,780 13.02 %

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

N/A Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease N/Ato hold: 12. Date on which proxy holder will cease to hold N/Avoting rights: 13. Additional information: N/A 14. Contact name: Calculus Capital Limited 15. Contact telephone number: 0207 493 4940

Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii A: Identity of the persons or legal entity subject to the notification obligation Full name (including legal form of legal entities) Contact address (registered office for legal entities) Phone number & email Other useful information (at least legal representative for legal persons)

B: Identity of the notifier, if applicable Full name Contact address Phone number & email Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

XLON
Date   Source Headline
2nd Nov 20205:00 pmRNSConvertible Loan Notes & Total Voting Rights
29th Oct 202010:15 amRNSResult of Open Offer and Adjournment of GM
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn
27th Oct 20204:36 pmRNSPrice Monitoring Extension
26th Oct 202010:10 amRNSConversion of Convertible Loan Notes
21st Oct 20204:12 pmRNSNotice of Annual General Meeting
16th Oct 20207:00 amRNSFinal Results for the year ended 30 April 2020
15th Oct 202011:10 amRNSHolding(s) in Company
14th Oct 202011:36 amRNSHolding(s) in Company
13th Oct 202012:07 pmRNSPosting of Circular
12th Oct 20207:00 amRNSProposed investment by Redmile and Open Offer
5th Oct 20207:00 amRNSNotice of Final Results
2nd Oct 20207:00 amRNSCollaboration to manufacture COVID-19 vaccine
24th Sep 20207:00 amRNSDirectorate Change
14th Sep 20204:41 pmRNSSecond Price Monitoring Extn
14th Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20209:05 amRNSSecond Price Monitoring Extn
14th Sep 20209:00 amRNSPrice Monitoring Extension
11th Sep 20204:41 pmRNSSecond Price Monitoring Extn
11th Sep 20204:35 pmRNSPrice Monitoring Extension
8th Sep 20204:40 pmRNSSecond Price Monitoring Extn
8th Sep 20204:35 pmRNSPrice Monitoring Extension
4th Sep 20207:00 amRNSDirector Award of Share Options
27th Aug 20207:00 amRNSFunds awarded by Innovate UK for COVID-19 vaccine
26th Aug 20204:02 pmRNSHolding(s) in Company
25th Aug 202010:11 amRNSHolding(s) in Company
12th Aug 20203:13 pmRNSHolding(s) in Company
12th Aug 202012:57 pmRNSDirector Dealing
11th Aug 202010:54 amRNSResults of General Meeting
23rd Jul 20204:44 pmRNSShareholder circular
22nd Jul 20201:51 pmRNSResult of Placing and Notice of General Meeting
22nd Jul 20207:00 amRNSProposed Capital Raise
24th Jun 20207:00 amRNSNew publication highlights potential of Modi-1
12th Jun 20209:30 amRNSPublication highlights potential of AvidiMab
1st May 20207:00 amRNSDirector salaries and award of share options
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:00 pmRNSPrice Monitoring Extension
28th Apr 202010:06 amRNSDirector Dealing
27th Apr 20204:39 pmRNSDirector Dealing
24th Apr 20202:05 pmRNSSecond Price Monitoring Extn
24th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSScancell: Development of vaccine against COVID-19
16th Mar 20204:42 pmRNSSecond Price Monitoring Extn
16th Mar 20204:38 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSScancell to Present at Three Research Conferences
3rd Feb 20207:00 amRNSSCIB1 IND Application Approved
31st Jan 20207:00 amRNSInterim Results
20th Jan 20207:00 amRNSThird agreement signed for antibody platform
17th Dec 201912:44 pmRNSDirector's Dealings
16th Dec 20197:00 amRNSSecond agreement signed for AvidiMab platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.